Oncocyte Corporation Common Stock

OCX XNAS • IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

77M

Short interest (May 30)

0.9%

Borrow Fee

0.56%

↓ 16.4%

Available Shares

20K

↓ 77.5%

Price Chart

Company Overview

OncoCyte Corp is a pioneering diagnostics technology company. Its mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers, or payers.

Company Info

Exchange: NASDAQ

Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

CIK: 0001642380

Asset Type: CS

Market Data

Market Cap: $77,218,069

Employees: 49

Status: Active

Short Interest

Current Borrow Fee 0.56%

Range: 0.56% - 0.67%

Available Shares 20K

Range: 15K - 15K

Recent Changes

Fee Change: ↑ 13.1%

Available Change: ↓ 0.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime